|
|
|
News Details
|
|
|
L-Sulpiride (Levosulpiride)
|
L-Sulpiride Launching
03/09/2008
Our medical representatives had attended the marketing/medical training of this product and they supposed to start the promotional work in this month (September)
Levosulpiride is a substituted benzamide, which exerts antidopaminergic (selective dopamine D2 receptors) activity on both central and peripheral levels. It is an atypical neuroleptic and a prokinetic agent.
It has been used nowadays in the symptomatic relieve of Irritable Bowl Syndrome, Gastroesophageal Reflux and Functional Dyspepsia.
The incidence of side effects with Levosulpiride is significantly less than Domperidone and Metoclopramide.
Recent studies showed that Cisapride but not Levosulpiride has structural properties similar to those of class III antiarrhythmic drugs, which delays repolarization and prolong QT interval. Hence, L-Sulpiride does not cause cardiac arrhythmias
For more information visit L-Sulpiride (Levosulpiride)
|
|
|